ArticleThe Journal of international medical research2026
Neutrophil extracellular traps biomarkers are associated with lung function obstruction severity in bronchial asthma.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo explore the value of neutrophil extracellular traps biomarkers (myeloperoxidase and citrullinated histone H3) in patients with bronchial asthma.MethodsA total of 66 patients with bronchial asthma (stratified into mild, moderate, and severe lung function obstruction subgroups according to predicted forced expiratory volume in 1 second) and 60 healthy controls were enrolled. Plasma levels of myeloperoxidase and citrullinated histone H3 were measured. Spearman correlation analysis and receiver operating characteristic curve analysis were used to evaluate correlations and diagnostic performance.ResultsCompared with healthy controls, patients with bronchial asthma had significantly higher plasma levels of myeloperoxidase and citrullinated histone H3 (all
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.